Li Li, Deputy Commissioner of the National Medical Products Administration, met with a Cuban delegation led by Miguel Angel Ramirez Ramos, outgoing Cuban ambassador to China on Oct 15.
China's first self-developed carbon-ion therapy system has been approved by the national drug regulator and obtained market access.
The International Medical Device Regulators Forum held its 16th management committee meeting on Sept 19 in Yekaterinburg, Russia.
- NMPA Promulgated the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor VIII and the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor IX
- NMPA Promulgated the Guidelines for Clinical Safety Literature Evaluation of Marketed Drugs (Interim)
- General Office of the State Council Issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019